60 research outputs found
PIN20 THE IMPACT OF COST-EFFECTIVENESS OF COUNTRY SPECIFIC APPLICATION—THE CASE OF DROTRECOGIN ALFA (ACTIVATED) IN SEVERE SEPSIS
The cost of illness attributable to diabetic foot and cost-effectiveness of secondary prevention in Peru
Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE Study
Aims/hypothesis Outcome data on individuals with diabetic foot ulcers are scarce, especially in those with peripheral arterial disease (PAD). We therefore examined the clinical characteristics that best predict poor outcome in a large population of diabetic foot ulcer patients and examined whether such predictors differ between patients with and without PAD. Methods Analyses were conducted within the EURODIALE Study, a prospective cohort study of 1,088 diabetic foot ulcer patients across 14 centres in Europe. Multiple logistic regression modelling was used to identify independent predictors of outcome (i.e. non-healing of the foot ulcer). Results After 1 year of follow-up, 23% of the patients had not healed. Independent baseline predictors of non-healing in the whole study population were older age, male sex, heart failure, the inability to stand or walk without help, end-stage renal disease, larger ulcer size, peripheral neuropathy and PAD. When analyses were performed according to PAD status, infection emerged as a specific predictor of non-healing in PAD patients only. Conclusions/Interpretation Predictors of healing differ between patients with and without PAD, suggesting that diabetic foot ulcers with or without concomitant PAD should be defined as two separate disease states. The observed negative impact of infection on healing that was confined to patients with PAD needs further investigation
PHL7 COST OF TREATMENT (COT) FOR VENOUS LEG ULCERS IN SWEDEN AND THE UK—ESTIMATES FROM CLINICAL EXPERT PANELS AND MODEL SIMULATIONS
PHL7 COST OF TREATMENT (COT) FOR VENOUS LEG ULCERS IN SWEDEN AND THE UK—ESTIMATES FROM CLINICAL EXPERT PANELS AND MODEL SIMULATIONS
PHL6 TREATMENT OF LEG ULCERS IN SWEDEN STILL DEMANDS LARGE RESOURCES IN SPITE OF IMPROVED MANAGEMENT—THE COST OF ILLNESS (COI) ESTIMATED FROM A PATIENT SURVEY AND PUBLISHED EPIDEMIOLOGICAL STUDIES
The inpatient care of patients with diabetes mellitus and foot ulcers. A validation study of the correspondence between medical records and the Swedish Inpatient Registry with the consequences for cost estimations
Hälsoekonomi och förbättrad läkemedelsanvändning - vad betyder ökad följsamhet till läkemedelsordination?
PUK12 LONG-TERM COST-EFFECTIVENESS MODELLING OF FEEDBACK MICROWAVE THERMOTHERAPY VERSUS DRUG TREATMENT IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA AND LOWER URINARY TRACT SYMPTOMS
- …